Company Name:Novavax Inc.
CEO: Stanley Charles Erck

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.


Key numbers

Market Capitalization:4731740104
Shares Outstanding: 57958600
Float: 57686658
Next Earning Date:2020-08-11
TTm EPS: -4.1453
TTm Dividend Rate:
200 days moving average:17.14
50 days moving average: 46.1
One day percent Change: 2.43



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,